Docusign (DOCU) Q4 2026 earnings review

IAM Surpasses $350M ARR as DocuSign Shifts Metrics; $2B Buyback Authorized

Docusign delivered stable 8% revenue growth in Q4, but the real story is beneath the hood: the Intelligent Agreement Management (IAM) platform exploded to 10.8% of total ARR (over $350M), proving its upsell thesis. The company is actively shedding its legacy focus on noisy quarterly billings, replacing it with ARR guidance (targeting an accelerating 8.5% growth in FY27). Supported by massive free cash flow generation ($350M in Q4), the Board authorized a massive $2.0 billion buyback, signaling high management confidence.

๐Ÿ‚ Bull Case

IAM is a Legitimate Growth Engine

IAM adoption is accelerating rapidly, jumping from 2.3% of ARR a year ago to 10.8% today. This validates the strategy of upselling higher-value AI platforms into the existing 1.8 million customer base.

Cash Machine Mentality

Free cash flow surged to $350.2 million in Q4 (a stunning 41.8% margin). This fully funds the aggressive new $2.0 billion stock repurchase program.

๐Ÿป Bear Case

Metric Opacity

Retiring the billings metric in favor of ARR reduces quarterly visibility into cash generation and renewal dynamics, a move that may frustrate investors accustomed to tracking short-term bookings momentum.

Top-Line Growth Still Single-Digit

Despite the massive success of IAM, overall revenue is still growing at a stable but unexciting 8%. The core eSignature business is mathematically anchoring the overall growth rate.

โš–๏ธ Verdict: ๐ŸŸข

Bullish. The successful scaling of IAM and a massive buyback authorization outweigh top-line growth that remains stuck in the high single digits. Moving to ARR is a sign of business maturity.

Key Themes

DRIVERNEW๐ŸŸข๐ŸŸข

IAM Platform Breaks Out

The Intelligent Agreement Management (IAM) platform is accelerating aggressively. As of Q4, IAM represented 10.8% of total ARR (approximately $353 million), up dramatically from just 2.3% a year ago. This confirms management's narrative from prior quarters that the GTM realignment and product focus on IAM is succeeding at scale.

THEMENEW๐ŸŸข

Strategic Metric Shift: Goodbye Billings, Hello ARR

Docusign announced it will no longer report or guide to billings starting in Q1 FY27. Management has repeatedly warned about renewal timing volatility impacting billings (e.g., the Q1 FY26 miss). By shifting focus to Annual Recurring Revenue (ARR) and guiding for 8.5% YoY growth in FY27, the company aims to provide a smoother, more predictable measure of business health.

DRIVERNEW๐ŸŸข

Aggressive Capital Returns Signal Confidence

With free cash flow accelerating to $350.2M in Q4, Docusign's board authorized a massive $2.0 billion increase to its share repurchase program. The company systematically increased its buyback pace every quarter throughout FY26, retiring $869.1M in total for the year.

DRIVERNEW๐ŸŸข

AI-Native Product Innovation

Docusign released 'Agreement Desk' and AI-Assisted Agreement Summaries in Q4. These tools leverage proprietary AI models to automate document tagging, generate redline suggestions, and quickly summarize complex contracts. This deepens the moat against generic LLM competitors and provides a clear upsell path.

CONCERN๐Ÿ”ด

Professional Services Drag

Professional services and other revenue remains a decelerating laggard. Q4 revenue in this segment fell 3% YoY to $17.9M, with a dismal Non-GAAP gross margin of 7.7% (and negative 15.0% on a GAAP basis). While a small piece of the overall pie, it continues to drag on total profitability.

CONCERNโšช

Margin Ceilings Reached?

While Non-GAAP operating margin was a healthy 29.5% in Q4, this represents a sequential decline from the 31.4% peak in Q3. FY27 guidance targets 30.0% - 30.5%, indicating that operating margins are now stable rather than expanding. Future bottom-line beats must come from top-line growth, not just cost-cutting.

Other KPIs

Q4 Free Cash Flow$350.2 million

Accelerating. Up from $279.6 million in the same period last year. The FCF margin hit an exceptional 41.8% in the quarter, underpinning the massive new buyback authorization.

Q4 Billings$1.019 billion

Stable. Grew 10% YoY. This is the final quarter Docusign will report this metric, bowing out on a high note by crossing the $1 billion threshold in a single quarter.

FY26 Total Revenue$3.22 billion

Stable. Up 8% YoY. Subscription revenue drove the vast majority of this at $3.15 billion (+9% YoY), offsetting the persistent weakness in professional services.

Guidance

FY27 ARR Growth8.25% to 8.75%

Accelerating. The midpoint of 8.50% represents an acceleration from the 8.0% ARR growth achieved in FY26. This metric is now the company's primary forward-looking indicator.

FY27 Total Revenue$3.484 to $3.496 billion

Stable. Implies roughly 8% YoY growth at the midpoint, perfectly consistent with the 8% growth printed in Q4 and the full year FY26.

FY27 Non-GAAP Operating Margin30.0% to 30.5%

Stable. Roughly in line with the 30.1% achieved for the full year FY26. Management is balancing reinvestment in IAM and AI with maintaining world-class profitability.

Key Questions

ARR Growth Drivers

With FY27 ARR growth guided to accelerate to a midpoint of 8.5%, how much of this acceleration is driven by expected IAM upsells versus core eSignature expansion or pricing changes?

Retiring Billings Metric

By eliminating billings guidance, investors lose a key view into working capital dynamics. Can you provide a framework for how we should model quarterly cash flow seasonality in a pure ARR reporting environment?

Capital Allocation Speed

You just authorized a massive $2.0 billion buyback increase. Given the sequential acceleration of repurchases throughout FY26, should we expect an even more aggressive cadence in FY27, or is this authorization meant to be deployed over multiple years?

Enterprise vs SMB IAM Mix

IAM has reached an impressive 10.8% of total ARR. Can you break down how much of this penetration is concentrated in the initial commercial/SMB segments versus large enterprise lands?